Thomas Ondet

Thomas Ondet, PhD, has been group leader at Sederma for 3 years in charge of epidermis, dermis and melanogenesis research. Prior to Sederma, he has a 10-year experience in skin biology acquired during his PhD on innate immunity in keratinocyte and then at Imagine Institute in genetic skin diseases. He also worked at Johnson and Johnson on cutaneous adverse drug reaction following oncology treatments among other topics.